FdaApplication
NDA 020646
Identifiers
- fda_app_no: NDA020646
Properties
| Property | Value |
|---|---|
| applicant_name | CEPHALON INC |
| application_type | NDA |
| approval_date | 1997-09-30 |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GABITRIL | TIAGABINE HYDROCHLORIDE | 16MG | TABLET;ORAL |
| GABITRIL | TIAGABINE HYDROCHLORIDE | 12MG | TABLET;ORAL |
| GABITRIL | TIAGABINE HYDROCHLORIDE | 2MG | TABLET;ORAL |
| GABITRIL | TIAGABINE HYDROCHLORIDE | 6MG | TABLET;ORAL |
| GABITRIL | TIAGABINE HYDROCHLORIDE | 10MG | TABLET;ORAL |
| GABITRIL | TIAGABINE HYDROCHLORIDE | 20MG | TABLET;ORAL |
| GABITRIL | TIAGABINE HYDROCHLORIDE | 4MG | TABLET;ORAL |
| GABITRIL | TIAGABINE HYDROCHLORIDE | 8MG | TABLET;ORAL |
8 products